Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

ACTON, Mass./WEST WARWICK, R.I., February 16, 2023 – Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), and Blood Centers of America (BCA) today announced that they have executed a collaborative agreement to develop commercial relationships to serve unmet needs by utilizing the SymphonyTM Platform in the blood and hospital markets.

More details.


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/lmbric5/public_html/ on line 5221